Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VitaminShoppe.com

This article was originally published in The Tan Sheet

Executive Summary

E-tailer gains access to 150,000 potential customers through deals with Oracle, OnlineBenefits, Arthur Andersen and PricewaterhouseCoopers, firm says May 31. The VitaminShoppe site will be available on the companies' corporate Intranets and will make available special promotional offers to employees. The "cost-effective" deal follows VitaminShoppe's plans to lower ad spending and eliminate TV spots; during the first quarter, the supplement e-tailer gained 50,000 new customers, giving it a total of 154,000 (1"The Tan Sheet" April 24, p. 14). The company also announces May 31 the launch of its upgraded Web site, which in addition to sporting a new look, offers enhanced features and faster access

You may also be interested in...



PlanetRx Store Brand Vitamins/Supplements Emphasize Quality; OTCs Coming

PlanetRx.com will launch a line of store brand OTCs including analgesics, antacids and cold/allergy products in late June to extend its new PlanetRx vitamins and supplements line, the online retailer announced April 20.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091291

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel